Glaucoma, a progressive optic neuropathy characterized by retinal ganglion cell
degeneration and visual field loss, is the leading cause of irreversible blindness worldwide …

Current glaucoma management centres on intraocular pressure (IOP) reduction through
pharmacological and surgical therapy. Despite broad interest in active management of …

Glaucoma is the second leading cause of blindness in the world, with an estimated 57.5
million people suffering from glaucoma globally. Treatment of glaucoma focuses on lowering …

Purpose To evaluate the effect of mindfulness-based stress reduction (MBSR) on intraocular
pressure (IOP) in patients with ocular hypertension (OHT). Design Parallel arm, single …

Mindfulness meditation has been shown to be beneficial for a range of different health
conditions, impacts brain function and structure relatively quickly, and has shown promise …

Objective: To study the effect of the “365 breathing technique” on IOP, autonomic functions,
and stress biomarkers in patients with primary open angle glaucoma. Methods: In this …

The aim of this perspective is to promote the theory of salutogenesis as a novel approach to
addressing ophthalmologic inflammatory conditions, illustrating several concepts in which it …

Purpose: To evaluate the AL in patients with POAG. Methods: This case-control study
comprised 50 POAG (glaucoma patients) and 50 age-matched controls without glaucoma …

Purpose: To evaluate visual cortex activity using fNIRS (Functional Near Infrared
Spectroscopy) in primary open angle glaucoma (POAG) and primary angle closure …

Reversing Aging and Improving Health Span in Glaucoma Patients: The Next Frontier? - PMC
Skip to main content Here's how you know Official websites use .gov A .gov website belongs …